Renal decline is not simply measured by eGFR. If you look at the research, UACR is a better indicator & prediction of other comorbidity in diabetes, as well as renal decline. Refer to KDIGO guidelines for International standards.
A big problem with both of these biomarkers is, that it does not indicate which patients will progress faster with DKD, particularly earlier on. There is a big hole here in diagnostics, although we have drugs now approved.
The picture should be pretty clear now in regards to PromarkerD.
- Forums
- ASX - By Stock
- PIQ
- Ann: Study shows diabetes drug improves PromarkerD risk scores
Ann: Study shows diabetes drug improves PromarkerD risk scores, page-37
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
85.0¢ |
Change
-0.020(2.30%) |
Mkt cap ! $111.3M |
Open | High | Low | Value | Volume |
87.0¢ | 88.0¢ | 84.5¢ | $104.5K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12500 | 85.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 2526 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12500 | 0.850 |
1 | 10000 | 0.840 |
2 | 4100 | 0.825 |
3 | 7365 | 0.820 |
1 | 3704 | 0.810 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 2526 | 1 |
0.880 | 37789 | 2 |
0.890 | 13245 | 1 |
0.900 | 12952 | 2 |
0.910 | 3200 | 1 |
Last trade - 15.32pm 15/08/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online